Many patients that are considered for a trial of a neuromodulation therapy are on chronic opioids. There is evidence to suggest that opioid therapy impacts not only the outcome of the neuromodulation trial but also the long-term success of therapy. This session will discuss the evidence and impact of opioids and neuropathic medications on the efficacy of neuromodulatory therapies.
- Evaluate the effect of titrating opioid medication prior to neuromodulatory therapies with regard to the efficacy.
- Explain the different ways to titrate opioids prior to neuromodulation therapies.
- Analyze the evidence of opioid reduction as a result of different neuromodulatory therapies.
Opioid Titration Prior to Neuromodulation
Jessica Jameson, MD
Opioid Reduction as Result of Neuromodulation
Maunak V Rana, MD